| Year |
Citation |
Score |
| 2020 |
de Mascena Costa LA, Debnath D, Harmon AC, de Sousa Araújo S, da Silva Souza HD, de Athayde Filho PF, Wischral A, Adrião Gomes Filho M, Mathis JM. Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4Bl in MCF-7 breast cancer cells. Oncology Letters. 20: 2291-2301. PMID 32782546 DOI: 10.3892/ol.2020.11763 |
0.312 |
|
| 2016 |
Siurala M, Vähä-Koskela M, Havunen R, Tähtinen S, Bramante S, Parviainen S, Mathis JM, Kanerva A, Hemminki A. Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. Oncoimmunology. 5: e1136046. PMID 27467954 DOI: 10.1080/2162402X.2015.1136046 |
0.331 |
|
| 2011 |
Coburn MA, Brueggemann S, Bhatia S, Cheng B, Li BD, Li XL, Luraguiz N, Maxuitenko YY, Orchard EA, Zhang S, Stoff-Khalili MA, Mathis JM, Kleiner-Hancock HE. Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea. Cancer Letters. 312: 82-90. PMID 21893382 DOI: 10.1016/J.Canlet.2011.08.003 |
0.329 |
|
| 2011 |
Pope M, Mathis J, Sun G, Kim R, Li B, Chu Q. CXCR4 Tumor Specific Promoter Restricts Oncolysis To Pancreatic Cancer Cell Lines That Overexpress CXCR4 Journal of Surgical Research. 165: 304-305. DOI: 10.1016/j.jss.2010.11.357 |
0.307 |
|
| 2010 |
Davis JN, Rogers D, Adams L, Yong T, Jung JS, Cheng B, Fennell K, Borazanci E, Moustafa YW, Sun A, Shi R, Glass J, Mathis JM, Williams BJ, Meyers S. Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells. Journal of Cellular Physiology. 225: 875-87. PMID 20607802 DOI: 10.1002/jcp.22298 |
0.374 |
|
| 2010 |
Balyasnikova IV, Franco-Gou R, Mathis JM, Lesniak MS. Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface. Journal of Tissue Engineering and Regenerative Medicine. 4: 247-58. PMID 19937911 DOI: 10.1002/Term.228 |
0.365 |
|
| 2009 |
Li XL, Zhang D, Knight D, Odaka Y, Glass J, Mathis JM, Zhang QJ. Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming. Immunology. 128: 420-8. PMID 20067541 DOI: 10.1111/j.1365-2567.2009.03127.x |
0.375 |
|
| 2009 |
Li XL, Liu YY, Knight D, Odaka Y, Mathis JM, Shi R, Glass J, Zhang QJ. Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression. Plos One. 4: e6385. PMID 19629186 DOI: 10.1371/Journal.Pone.0006385 |
0.488 |
|
| 2008 |
Li XL, Zhang DQ, Wang D, Knight DS, Yin L, Bao J, Liu YY, Glass J, Mathis JM, Zhang QJ. In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 29: 359-70. PMID 19052485 DOI: 10.1159/000178981 |
0.495 |
|
| 2008 |
Zhang QJ, Li XL, Wang D, Huang XC, Mathis JM, Duan WM, Knight D, Shi R, Glass J, Zhang DQ, Eisenbach L, Jefferies WA. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. Plos One. 3: e3097. PMID 18769733 DOI: 10.1371/Journal.Pone.0003097 |
0.39 |
|
| 2008 |
Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells (Dayton, Ohio). 26: 831-41. PMID 18192232 DOI: 10.1634/stemcells.2007-0758 |
0.318 |
|
| 2007 |
Zhu ZB, Mathis JM, Makhija SK, Lu B, Wang M, Ji S, Rivera AA, Rosenthal EL, Siegal GP, Curiel DT. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck. International Journal of Oncology. 31: 1213-22. PMID 17912450 DOI: 10.3892/Ijo.31.5.1213 |
0.301 |
|
| 2007 |
Ulasov IV, Rivera AA, Nettelbeck DM, Rivera LB, Mathis JM, Sonabend AM, Tyler M, Wang M, Douglas JT, Lesniak MS. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy. International Journal of Oncology. 31: 1177-85. PMID 17912445 DOI: 10.3892/Ijo.31.5.1177 |
0.359 |
|
| 2006 |
Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control. The Journal of Gene Medicine. 8: 1105-20. PMID 16802401 DOI: 10.1002/jgm.935 |
0.389 |
|
| 2006 |
Sibley DA, Barlow S, DeBenedetti R, Curiel DT, Mathis JM. 843. MicroPET Imaging of HSV-TK Activity To Assess Cancer-Specific Gene Expression Targeted at the Level of Protein Translation Initiation Molecular Therapy. 13: S326. DOI: 10.1016/J.Ymthe.2006.08.929 |
0.397 |
|
| 1994 |
Orth K, Hung J, Gazdar A, Bowcock A, Mathis JM, Sambrook J. Genetic instability in human ovarian cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America. 91: 9495-9. PMID 7937795 DOI: 10.1073/Pnas.91.20.9495 |
0.328 |
|
| Show low-probability matches. |